Global Medical Foods Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Analyse du marché des aliments médicaux

Le marché des aliments médicaux connaît une croissance soutenue, tirée par la prévalence croissante des maladies chroniques et des troubles métaboliques, ainsi que par une prise de conscience croissante du rôle de la nutrition sur mesure dans la gestion des problèmes de santé. Le marché se caractérise par une demande croissante de produits nutritionnels spécialisés conçus pour répondre aux besoins alimentaires spécifiques des patients atteints de maladies telles que le diabète, la phénylcétonurie (PCU) et les maladies gastro-intestinales. Les progrès de la recherche médicale et le développement de formulations innovantes contribuent à l'expansion de ce marché. Le marché connaît également une évolution vers la nutrition personnalisée, les entreprises se concentrant sur le développement de produits adaptés à des profils génétiques ou à des problèmes de santé spécifiques. Cette tendance devrait favoriser la croissance du marché, car les aliments médicaux personnalisés offrent des solutions ciblées pour la gestion de problèmes de santé complexes.

Taille du marché des aliments médicaux

Français La taille du marché mondial des aliments médicaux a été évaluée à 23,50 milliards USD en 2023 et devrait atteindre 36,62 milliards USD d'ici 2031, avec un TCAC de 5,70 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, une analyse des prix, une analyse de la part de marque, une enquête auprès des consommateurs, une analyse démographique, une analyse de la chaîne d'approvisionnement, une analyse de la chaîne de valeur, un aperçu des matières premières/consommables, des critères de sélection des fournisseurs, une analyse PESTLE, une analyse Porter et un cadre réglementaire.

Tendances du marché des aliments médicaux

« Progrès dans la recherche médicale »

Les innovations dans la recherche médicale façonnent considérablement le paysage du marché des aliments médicaux, conduisant au développement de produits nutritionnels plus efficaces et ciblés. Les progrès récents dans les domaines de la biotechnologie, de la génomique et de la recherche clinique ont permis la création d’aliments médicaux spécifiquement formulés pour répondre aux besoins alimentaires uniques des personnes souffrant de divers problèmes de santé. Ces innovations permettent un ciblage plus précis des interventions nutritionnelles, améliorant à la fois l’efficacité et l’attrait des aliments médicaux. Par exemple, la recherche sur les voies métaboliques et les profils génétiques a conduit au développement de formulations personnalisées qui répondent à des variations génétiques ou à des états pathologiques spécifiques, offrant des solutions sur mesure qui étaient auparavant inaccessibles.

De plus, les progrès réalisés dans la science des ingrédients et les mécanismes de distribution améliorent la biodisponibilité et l’efficacité des nutriments clés. À mesure que la recherche médicale continue d’évoluer, la capacité à développer des aliments médicaux hautement spécialisés qui répondent à des problèmes de santé complexes devrait stimuler la croissance du marché, répondant à une demande croissante de soutien nutritionnel personnalisé et spécifique à chaque condition. Cette tendance souligne le rôle de la recherche de pointe dans l’avancement du secteur des aliments médicaux et la satisfaction des besoins évolutifs des patients et des prestataires de soins de santé.

Portée du rapport et segmentation du marché        des aliments médicaux

Définition du marché des aliments médicaux

Medical foods are formulated to meet the specific nutritional needs of individuals with certain medical conditions or diseases. These foods are intended for the dietary management of conditions that cannot be addressed through normal diet alone. They are used under medical supervision and are designed to provide necessary nutrients in precise amounts, often to support medical treatment or manage disease symptoms. 

Medical Foods Market Dynamics

Drivers 

• Rising Prevalence of Chronic Diseases 

With health issues, including diabetes, cardiovascular conditions, and metabolic disorders, becoming more widespread, there is a heightened need for specialized nutritional products that address the specific dietary requirements of individuals affected by these conditions. Medical foods are designed to aid in the management and treatment of chronic diseases by providing essential nutrients and functional components not readily available through a standard diet. This expanding patient population, combined with the understanding that targeted nutrition is vital for effective disease management, is propelling the growth of the medical foods market. For instance, in May 2024, Nestlé is set to introduce a new frozen-food brand, Vital Pursuit, specifically designed for consumers using Ozempic and Wegovy. The rising popularity of GLP-1 drugs for weight loss and diabetes management has notably increased. This growing prevalence of chronic diseases is driving a notable increase in the demand for medical foods.

• Growing Awareness of Nutritional Management               

Increased awareness of the importance of dietary management and nutrition in treating and preventing diseases is a major driver of the medical foods market. Both consumers and healthcare professionals are increasingly acknowledging that nutrition plays a critical role in not only maintaining overall health but also in managing specific medical conditions. This heightened awareness has resulted in a greater emphasis on incorporating medical foods into comprehensive treatment plans to address nutritional deficiencies and enhance health outcomes. As individuals become more educated about the advantages of customized nutritional interventions, the demand for medical foods that cater to these needs is rising. This trend towards preventive and supportive dietary approaches highlights the growing significance of medical foods in contemporary healthcare.

Opportunities

• Rising Demand for Preventive Healthcare

Both healthcare systems and consumers are increasingly prioritizing disease prevention over treatment, leading to a higher demand for products that promote health maintenance and prevent illness. Medical foods, designed to meet specific nutritional needs and support overall well-being, are well-suited to address this demand. By supplying essential nutrients that enhance immune function, regulate weight, and support metabolic health, these products play a key role in preventive care strategies. The trend towards proactive health management highlights the need for innovative medical foods that align with preventive health objectives. The growing emphasis on preventive healthcare offers significant opportunities for the medical foods market.

• Aging Population Needs

The medical foods market is experiencing notable growth due to the nutritional needs of an aging population. As the global demographic shifts towards older age groups, there is a rising demand for specialized nutritional products tailored to address age-related health challenges. Elderly individuals often require specific nutritional support to manage chronic conditions, maintain bone and muscle health, and improve cognitive function. Medical foods designed to meet these needs can enhance the quality of life for older adults by filling dietary gaps and promoting overall health. This demographic shift presents a significant market opportunity for medical foods that cater to the unique health requirements of the aging population, driving both innovation and market expansion.

Restraints/Challenges

• High Development Costs

The high development costs associated with medical foods pose a significant challenge to market growth. Developing and manufacturing medical foods involves extensive research, clinical trials, and regulatory compliance, all of which contribute to substantial financial investments. These costs can limit the ability of companies to invest in new product development and bring innovative solutions to market. Additionally, the need for robust clinical evidence to support the efficacy and safety of medical foods further increases development expenses. As a result, the high costs associated with research and development can constrain market entry for new players and impact the overall pace of innovation in the medical foods sector.

• Limited Awareness in Emerging Markets

Limited awareness and understanding of medical foods in emerging markets can restrict market growth in these regions. In many emerging economies, the concept of medical foods is relatively new, and there may be a lack of familiarity with their benefits and applications. This limited awareness can hinder consumer adoption and reduce the overall demand for medical foods. Additionally, healthcare infrastructure in these regions may not be fully equipped to support the use of specialized nutritional products, further impeding market expansion.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Global Medical Foods Market Scope

The market is segmented on the basis of product type, application, form, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Nutritionally Complete Formulas
• Nutritionally Incomplete Formulas
• Oral Rehydration Products

Application

• ADHD
• Depression
• Diabetes
• Cancer
• Alzheimer’s Disease
• Metabolic Disorders
• Others

Form

• Powders
• Liquid
• Capsules
• Tablets
• Bars

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• Supermarkets

Global Medical Foods Market Regional Analysis

The market is analyzed and market size insights and trends are provided by country, product type, application, form, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to the presence of major key players in the region. Additionally, strategic initiatives by these players and the rising prevalence of chronic conditions are expected to further drive market growth in North America during the forecast period.  

Asia-Pacific is expected to be the fastest growing due to an increase in diseases such as diabetes, malnutrition, obesity, cancer, and cardiovascular conditions. The presence of significant local players is also anticipated to contribute to the market's expansion in this region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Global Medical Foods Market Share

The market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Medical Foods Market Leaders Operating in the Market Are:

• Danone S.A. (France)
• Nestlé (Switzerland)
• Abbott (U.S.)
• Primus Pharmaceuticals, Inc. (U.S.)
• Mead Johnson & Company, LLC. (U.S.)
• Medtrition, Inc. (U.S.)
• Fresenius Kabi AG (Germany)
• Meiji Holdings Co., Ltd. (Japan)
• Reckitt Benckiser Group PLC (U.K.)
• Cerecin Inc. (U.S.)
• Metagenics (U.S.)
• ENTERA HEALTHCARE (U.S.)
• Bausch Health Companies Inc. (Canada)
• Upsher-Smith Laboratories, LLC (U.S.)

Latest Developments in Medical Foods Market

• In December 2023, Life Health Foods (India) Pvt. Ltd., a pioneer in the plant-based beverage segment, launched the new vegan drink So Good Oat Caramel beverage—a dairy-free, plant-based milk. The new So Good Oat Caramel beverage delivered on the brand's promise of being a healthy and versatile drink
• In November 2023, Arla Foods Ingredients and Danone introduced new adult nutrition products in China. Amid shifting market dynamics, more manufacturers are redirecting their infant nutrition ingredients into other nutrition segments

SKU-66483